| Date | Title | Description | Source |
| 08.01.2021 | Venrock’s Bryan Roberts on the firm’s new $450 million fund,... | Venrock, the 51-year-old firm that started as the venture arm of the Rockefeller family, has closed ... | techcrunch... |
| 12.06.2020 | Novo Nordisk To Buy Corvidia Therapeutics For Up To $2.1B | 23 Shares Email Facebook Twitter LinkedIn
Danish pharmaceutical company Novo Nordisk is buying Mass... | news.crunc... |
| 25.04.2018 | Corvidia Therapeutics Secures $60 Million in Series B Fundin... | Lead investor Venrock joined by Andera, Cormorant, HBM Healthcare Investments, Fresenius Medical Car... | venturebea... |
| 25.04.2018 | Corvidia Therapeutics Secures $60 Million in Series B Fundin... |
Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, announced the close ... | anderapart... |
| 25.04.2018 | Corvidia Therapeutics Raises $60 Million in Series B | WALTHAM, Mass.--(BUSINESS WIRE)--Corvidia Therapeutics Inc., a leading clinical stage biotechnology ... | citybizlis... |
| 25.04.2018 | Venrock-backed startup Corvidia snags $60M round to deve... | A new startup founded by a handful of ex-AstraZeneca folks has hauled in a $60 million Series ... | endpts.com... |
| 25.04.2018 | Corvidia Therapeutics Secures $60M in Series B Funding | Corvidia Therapeutics Inc., a Waltham, Mass.-based clinical stage biotechnology company, closed a $6... | finsmes.co... |
| 18.02.2016 | Corvidia Therapeutics Raises $26M in a Series A |
BOSTON, MA, Biotechnology company focused on the development of precision cardiovascular therapies... | vcnewsdail... |
| 17.02.2016 | Corvidia Therapeutics Raises $26M in a Series A Financing, L... | Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascula... | appletreep... |
| 17.02.2016 | Corvidia Therapeutics Raises $26M in Series A Funding | Corvidia Therapeutics, a Boston, MA-based biotechnology company focused on the development of precis... | finsmes.co... |
